-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Cumberland Pharmaceuticals Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2010 to 2023.
- Cumberland Pharmaceuticals Inc Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $11.4K, a 64.9% increase year-over-year.
- Cumberland Pharmaceuticals Inc Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $59.3K, a 14% decline year-over-year.
- Cumberland Pharmaceuticals Inc annual Income Tax Expense (Benefit) for 2023 was $45.8K, a 33.5% decline from 2022.
- Cumberland Pharmaceuticals Inc annual Income Tax Expense (Benefit) for 2022 was $68.9K, a 97.3% increase from 2021.
- Cumberland Pharmaceuticals Inc annual Income Tax Expense (Benefit) for 2021 was $34.9K, a 37.6% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)